Article
Saturday was the day 2 with many posters and live sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day two:
All News
Article
Combination therapy with biologic and conventional DMARDs can be highly effective at inducing remission in patients with RA. Once controlled, patients are often interested in stopping combination drug therapy due to concerns related to medication burdens, side effect profiles, or safety.
Dr. John Cush
Tweet
Study of 351 SLE patients from Leiden shows that SLE with Neuropsychatric disease do not have a higher mortality than lupus without CNS disease; but do have higher mortality than gen. population #ACR20 Abstr#1264 https://t.co/CmBjfUj1Ur https://t.co/WYZQDaI4yt
Janet Pope
Tweet
Who will clot in #Lupus? 150 with SLE, clots ^ if PC4d + = market of plt Activation & arterial thrombosis abstr#1510 needs validation in another SLE group. V interesting @RheumNow @CRASCRRheum #ACR20 https://t.co/UBGxaFwhwZ
k dao
Tweet
ACR/AF JIA guidelines presented @ACR20:
👉Initiate DMARD early over NSAID monotherapy
👉Use SQ MTX> oral MTX > SSZ/LEF
👉add biologic preferred over triple DMARD
👉DON'T use chronic low dose steroids
👉combo biologic+DMARD > biologic monoRx
https://t.co/lwoFSTuV91
@rheumnow https://t.co/wzh2LCS0dN
Dr. Rachel Tate
Tweet
History of IBS, more aggressive disease phenotype & active SpA before conception or during pregnancy increased the risk for adverse pregnancy outcome. #ABS1324 #ACR20 @RheumNow https://t.co/NQ6kDMSaJ3 https://t.co/I3sxRmPL6j
Dr. John Cush
Tweet
821 SLE pts from Hopkins lupus clinic showed that LAC was best predictor of venous + arterial thromboses. β2glycoproteinI IgA (+) also important! #ACR20 #Abstr#1261 https://t.co/H0hz9Gp5Hy https://t.co/Vpiih4LyuZ
Dr. Antoni Chan
Tweet
In our quest to reduce delays to diagnosis in axSpA, this paper in patients with psoriasis, AAU and IBD, the ASAS-modification of the Berlin algorithm was superior to the original algorithm, with enhanced sensitivity @RheumNow #ACR20 Abstr#1303
Meral K. El Ramahi, MD
Tweet
Do you recommend Omega-3 fish oil (2-9 grams per day) to your patients with RA (doubled blinded RCT in 140 pts w/ recent onset of RA showed increased likelihood of achieving remission & less failure of triple therapy in high-dose fish oil group). #ACR20 @RheumNow @LCalabreseDO
sheila
Tweet
This study shows that serum anti-PAD4, anti-PAD3/4XR abs are highly specific for RA-ILD and assoc'd w/ better lung function in RA-UIP.
Small patient sample. Potential prognostic biomarker? @RheumNow #ACR20 abs1200 https://t.co/f5VFjJhVXF
Richard Conway
Tweet
Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score matching. No difference in risk between MTX and HCQ overall. Increase BCC in MTX (HR 1.32) but less SCC (HR 0.77) @rheumnow #ACR20 Abstr#1001 https://t.co/LDWgfGK9LS
David Liew
Tweet
Nintedanib in rheum ILD (RA/SSc/CTD)
I appreciate the volumes might not seem like much, but:
- in first 1y Rx 20% more are spared a FVC decline>10%
- biggest diff in UIP-like pattern
With the right patient selection, nintedanib does have its place!
#ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
alexa meara
Tweet
Great thoughts-how do we define seronegative RA as well? more studies like this are needed for patient centered medicine! @ACRheum @RheumNow @OSUWexMed #ACR20 https://t.co/7fUO70t09u
Richard Conway
Tweet
Watch my video discussing the SEAM-RA trial of treatment reduction in RA patients in remission on @rheumnow #ACR20 https://t.co/YDfBafBdRs
Peter Nash
Tweet
Factors Associated to Clinical and Radiographic Disease Progression in Patients with Early RA and First-degree Relatives: A 1-year Follow-up https://t.co/GWboXit6m1 #RA #firstdegreerelatives obesity and periodontal disease drive risk - both preventable
Meral K. El Ramahi, MD
Tweet
So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20
Peter Nash
Tweet
Minimum Clinically Important Improvement in Patients with Rheumatoid Arthritis Associates with Gut Microbiome https://t.co/D3ILR57gXY #RA #microbiome that microbiome again
Peter Nash
Tweet
Time to Discontinuation of Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients with and Without Methotrexate: Real World Results from a Rheumatoid Arthritis Cohort https://t.co/ZzhE0J7dOX #TOFA #TNFi TNFi does better with MTX Tofa less necessary
Dr. Antoni Chan
Tweet
Etanercept monotherapy significantly more effective than Methotrexate monotherapy in maintaining remission in RA patients on combination therapy. Data from the SEAM-RA study @RheumNow #ACR20 Abstr#0939 #ACRbest
Dr. John Cush
Tweet
Rheumatoid arthritis and lung disease in the spotlight at #ACR20 by @jeffsparks
https://t.co/0Dth0k6uve https://t.co/pGfGtq8Sz7
